Učitavanje...
Telotristat ethyl: a novel agent for the therapy of carcinoid syndrome diarrhea
Carcinoid syndrome (CS), characterized by diarrhea and flushing, is present in 20% of patients with neuroendocrine tumors at diagnosis and becomes more frequent with progression. The diarrhea of CS is caused mainly by tumoral secretion of serotonin. It may not be fully controlled by somatostatin ana...
Spremljeno u:
| Izdano u: | Future Oncol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Future Medicine Ltd
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6734517/ https://ncbi.nlm.nih.gov/pubmed/29350062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2017-0340 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|